HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen D Wright Selected Research

Drug Therapy (Chemotherapy)

1/2018Establishing a Preclinical Multidisciplinary Board for Brain Tumors.
1/2015Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy.
12/2012Current treatment options for pediatric and adult patients with ependymoma.
10/2009New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.
9/2009Late effects of treatment for wilms tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen D Wright Research Topics

Disease

12Neoplasms (Cancer)
01/2022 - 04/2012
8Brain Neoplasms (Brain Tumor)
01/2022 - 01/2009
7Ependymoma
01/2021 - 10/2009
5Glioma (Gliomas)
11/2022 - 12/2019
2Diffuse Intrinsic Pontine Glioma
10/2018 - 06/2015
2Medulloblastoma
09/2017 - 08/2012
2Central Nervous System Neoplasms
04/2015 - 01/2015
1Disease Progression
01/2021
1Choroid Plexus Carcinoma
01/2018
1Primary Ovarian Insufficiency
01/2015
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2013
1Necrosis
08/2012
1Rhabdoid Tumor (Rhabdoid Tumors)
04/2012
1Retinoblastoma (Glioblastoma, Retinal)
09/2010
1Familial ependymoma
10/2009
1Wilms Tumor (Wilm's Tumor)
09/2009

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2019
2Biological ProductsIBA
11/2019 - 10/2009
2dipinacoline glutamateIBA
10/2018 - 06/2015
2Methotrexate (Mexate)FDA LinkGeneric
04/2015 - 01/2015
1Phosphotransferases (Kinase)IBA
01/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1tyrosine receptor (receptor, tyrosine)IBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1EverolimusFDA Link
01/2021
1TabletsIBA
01/2021
1RNA (Ribonucleic Acid)IBA
11/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1MTOR InhibitorsIBA
01/2019
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2018
1HhAntag691IBA
09/2017
1NucleotidesIBA
07/2017
1vasectrin IIIIBA
01/2017
1Fluorouracil (Carac)FDA LinkGeneric
12/2015
1Alkylating AgentsIBA
01/2015
1Therapeutic UsesIBA
08/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2012
1Vincristine (Oncovin)FDA LinkGeneric
08/2012
1Cisplatin (Platino)FDA LinkGeneric
08/2012

Therapy/Procedure

15Therapeutics
11/2022 - 01/2009
5Radiotherapy
12/2019 - 09/2009
5Drug Therapy (Chemotherapy)
01/2018 - 09/2009
3Craniospinal Irradiation
01/2015 - 04/2012
2Precision Medicine
01/2022 - 07/2017
1Molecular Targeted Therapy
11/2022
1Adjuvant Chemotherapy
01/2015
1Conformal Radiotherapy
08/2012